Home/Hedge Fund Intelligence/Enliven Therapeutics, Inc.
Nasdaq: ELVNStockForm 13F30 Jun 2026

Hedge funds that hold Enliven Therapeutics, Inc. Nasdaq: ELVN

CUSIP 29337E102 · who reports it, how much, and how much it matters to them

38 of the 720 hedge fund managers we track reported shares of Enliven Therapeutics, Inc. (Nasdaq: ELVN) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to Orbimed Advisors, at USD 344m.

Managers reporting it38of 720 we track
Value they reportUSD 1.2bnshares only, 30 Jun 2026
Funds they run617with a file on PPLI.com
Largest positionUSD 344mOrbimed Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight6.4%Orbimed Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

38 managers, USD 1.2bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Enliven Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Orbimed Advisors1 fund on PPLI.comUSD 344m6.4%
2Polar Capital LLP26 funds on PPLI.comUSD 326m0.8%
3Citadel Advisors32 funds on PPLI.comUSD 105m0.0%
4Fairmount Funds Management2 funds on PPLI.comUSD 94m6.2%
5Adage Capital Management1 fund on PPLI.comUSD 55m0.1%
6Samlyn Capital8 funds on PPLI.comUSD 46m0.8%
7Baker Bros. Advisors2 funds on PPLI.comUSD 46m0.2%
8Balyasny Asset Management25 funds on PPLI.comUSD 31m0.0%
9Marshall Wace LLP84 funds on PPLI.comUSD 27m0.0%
10Logos Global Management1 fund on PPLI.comUSD 24m1.0%
11Rock Springs Capital Management2 funds on PPLI.comUSD 24m1.2%
12Millennium Management6 funds on PPLI.comUSD 21m0.0%
13D. E. Shaw & Co.15 funds on PPLI.comUSD 16m0.0%
14Deep Track Capital1 fund on PPLI.comUSD 11m0.2%
15Cormorant Asset Management1 fund on PPLI.comUSD 7.6m0.4%
16HighVista Strategies27 funds on PPLI.comUSD 7m1.6%
17Eversept Partners3 funds on PPLI.comUSD 6.9m0.4%
18Sphera Funds Management1 fund on PPLI.comUSD 5.7m0.7%
19J. Goldman & Co.1 fund on PPLI.comUSD 5.7m0.1%
20Cinctive Capital Management5 funds on PPLI.comUSD 5.5m0.2%
21Exome Asset Management2 funds on PPLI.comUSD 5.1m3.1%
22Artia Global Partners1 fund on PPLI.comUSD 3.7m0.7%
23Great Point Partners2 funds on PPLI.comUSD 3.6m0.7%
24Schonfeld Strategic Advisors30 funds on PPLI.comUSD 2.8m0.0%
25Atom Investors1 fund on PPLI.comUSD 2.5m0.2%
26Tudor Investment Corporation10 funds on PPLI.comUSD 2m0.0%
27Boothbay Fund Management2 funds on PPLI.comUSD 2m0.0%
28Brevan Howard Capital Management39 funds on PPLI.comUSD 1.7m0.0%
29Engineers Gate Manager1 fund on PPLI.comUSD 1.5m0.0%
30Two Sigma Investments35 funds on PPLI.comUSD 1.2m0.0%
31Lighthouse Investment Partners190 funds on PPLI.comUSD 1m0.0%
32Hudson Bay Capital Management8 funds on PPLI.comUSD 964,0000.0%
33Verdad Advisers6 funds on PPLI.comUSD 861,0000.8%
34Capstone Investment Advisors25 funds on PPLI.comUSD 537,0000.0%
35Persistent Asset Partners10 funds on PPLI.comUSD 479,0000.1%
36Aquatic Capital Management3 funds on PPLI.comUSD 426,0000.0%
37Squarepoint Ops7 funds on PPLI.comUSD 259,0000.0%
38The Quarry1 fund on PPLI.comUSD 205,0000.0%
Next: where it matters most
Where it matters most

For Orbimed Advisors it is 6.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Orbimed AdvisorsUSD 344m6.4%
2Fairmount Funds ManagementUSD 94m6.2%
3Exome Asset ManagementUSD 5.1m3.1%
4HighVista StrategiesUSD 7m1.6%
5Rock Springs Capital ManagementUSD 24m1.2%
6Logos Global ManagementUSD 24m1.0%
7Verdad AdvisersUSD 861,0000.8%
8Polar Capital LLPUSD 326m0.8%
9Samlyn CapitalUSD 46m0.8%
10Sphera Funds ManagementUSD 5.7m0.7%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Enliven Therapeutics, Inc.

What is the ticker symbol of Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. trades under the symbol ELVN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 29337E102.

Which hedge funds own Enliven Therapeutics, Inc. (Nasdaq: ELVN)?

38 of the 720 hedge fund managers PPLI.com tracks reported Enliven Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Orbimed Advisors (USD 344m), Polar Capital LLP (USD 326m), Citadel Advisors (USD 105m), Fairmount Funds Management (USD 94m) and Adage Capital Management (USD 55m).

How many hedge funds hold Enliven Therapeutics, Inc.?

38 managers in our coverage reported it, and between them they run 617 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Enliven Therapeutics, Inc.?

Orbimed Advisors, where the position was 6.4% of the reported 13F book at 30 June 2026.

Does this show who is short Enliven Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Enliven Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.